Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H12Cl2N2O |
| Molecular Weight | 319.185 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C3=CC=CC=C3Cl
InChI
InChIKey=VPAYQWRBBOGGPY-UHFFFAOYSA-N
InChI=1S/C16H12Cl2N2O/c1-20-14-7-6-10(17)8-12(14)16(19-9-15(20)21)11-4-2-3-5-13(11)18/h2-8H,9H2,1H3
| Molecular Formula | C16H12Cl2N2O |
| Molecular Weight | 319.185 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://dx.doi.org/10.1016/j.forsciint.2016.09.006Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24604775
Sources: http://dx.doi.org/10.1016/j.forsciint.2016.09.006
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24604775
Dicazepam (known as Ro5-3448, chlorodiazepam and 2'-chloro-diazepam) is a 2’-chloro derivative of diazepam that has emerged as a designer drug and is intended for forensic and research applications. It is metabolized in vivo into the pharmacologically active which can be detected in urine.
Originator
Sources: https://www.google.com/patents/US3136815
Curator's Comment: # Leo Sternbach and his team at Hoffman-La Roche
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24604775
one tablet of diclazepam (declared amount: 1 mg) was ingested
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:58:38 GMT 2025
by
admin
on
Mon Mar 31 18:58:38 GMT 2025
|
| Record UNII |
070818R7PB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Diclazepam
Created by
admin on Mon Mar 31 18:58:38 GMT 2025 , Edited by admin on Mon Mar 31 18:58:38 GMT 2025
|
||
|
DEA NO. |
2789
Created by
admin on Mon Mar 31 18:58:38 GMT 2025 , Edited by admin on Mon Mar 31 18:58:38 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6959
Created by
admin on Mon Mar 31 18:58:38 GMT 2025 , Edited by admin on Mon Mar 31 18:58:38 GMT 2025
|
PRIMARY | |||
|
100000164745
Created by
admin on Mon Mar 31 18:58:38 GMT 2025 , Edited by admin on Mon Mar 31 18:58:38 GMT 2025
|
PRIMARY | |||
|
C020967
Created by
admin on Mon Mar 31 18:58:38 GMT 2025 , Edited by admin on Mon Mar 31 18:58:38 GMT 2025
|
PRIMARY | |||
|
SUB179332
Created by
admin on Mon Mar 31 18:58:38 GMT 2025 , Edited by admin on Mon Mar 31 18:58:38 GMT 2025
|
PRIMARY | |||
|
76168
Created by
admin on Mon Mar 31 18:58:38 GMT 2025 , Edited by admin on Mon Mar 31 18:58:38 GMT 2025
|
PRIMARY | |||
|
070818R7PB
Created by
admin on Mon Mar 31 18:58:38 GMT 2025 , Edited by admin on Mon Mar 31 18:58:38 GMT 2025
|
PRIMARY | |||
|
DICLAZEPAM
Created by
admin on Mon Mar 31 18:58:38 GMT 2025 , Edited by admin on Mon Mar 31 18:58:38 GMT 2025
|
PRIMARY | |||
|
2894-68-0
Created by
admin on Mon Mar 31 18:58:38 GMT 2025 , Edited by admin on Mon Mar 31 18:58:38 GMT 2025
|
PRIMARY | |||
|
DTXSID30183138
Created by
admin on Mon Mar 31 18:58:38 GMT 2025 , Edited by admin on Mon Mar 31 18:58:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|